Nicholas Soulakis, PhD, assistant professor of Preventive Medicine in the Divisions of Health and Biomedical Informatics and Epidemiology, discussed lessons learned from his experience leading COVID-19 contract tracing efforts for the Illinois Department of Public Health during a recent webinar.
Monthly Archives: October, 2020
Measuring acid reflux with a wireless electrode can help clinicians determine if patients can stop taking proton pump inhibitors, a medication commonly prescribed for gastroesophageal reflux disease.
The impact of COVID-19 on cancer patients has been a stark reality for many cancer centers around the world. For the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a combination of time and dedication to patient care and research has resulted in the development of robust COVID-19 testing protocols to ensure the safety and health of every patient, physician and staff member.
Maxwell Edmonds, a third-year medical student in the Medical Scientist Training Program (MSTP), recently defended his doctoral thesis on generating testicular organoids and looks back on his Feinberg journey so far.
William Grobman, MD, MBA, ’97 ’00 GME, vice chair for clinical operations and the Arthur Hale Curtis, MD, Professor of Obstetrics and Gynecology, has been elected to the National Academy of Medicine.
A rare genetic mutation found in patients with Alzheimer’s may provide further insight into the pathologic mechanisms that cause the disease.
Treatment-resistant breast cancer could be made vulnerable to immunotherapy by flipping a metabolic “switch,” according to a new Northwestern Medicine study.
A group of scientists combined medicinal chemistry and human stem cells to improve a medication treating a cardiac rhythm disorder, a strategy that could be applied broadly.
The COVID-19 contact tracing process, led by health departments across the state, and coordinated by the Illinois Department of Public Health, involves a team of dedicated team members tracking the spread of the disease.
A new study found that Black men with metastatic prostate cancer were more likely to have tumor mutations than white or Asian men, highlighting the significance genetic drivers have in increasing one’s risk for developing aggressive prostate cancer.